Erin Colgan is CHIEF FINANCIAL OFFICER of Sensei Biotherapeutics, Inc.. Currently has a direct ownership of 67,462 shares of SNSE, which is worth approximately $30,357. The most recent transaction as insider was on Feb 15, 2024, when has been sold 3,627 shares (Common Stock) at a price of $0.79 per share, resulting in proceeds of $2,865. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 67.5K
0% 3M change
0.92% 12M change
Total Value Held $30,357

Erin Colgan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2024
SELL
Payment of exercise price or tax liability
$2,865 $0.79 p/Share
3,627 Reduced 5.1%
67,462 Common Stock
Feb 15 2023
SELL
Payment of exercise price or tax liability
$16,414 $1.5 p/Share
10,943 Reduced 13.85%
68,089 Common Stock
Feb 15 2023
BUY
Grant, award, or other acquisition
-
51,346 Added 41.28%
73,032 Common Stock
Feb 15 2022
BUY
Grant, award, or other acquisition
-
21,000 Added 49.2%
21,686 Common Stock
EC

Erin Colgan

CHIEF FINANCIAL OFFICER
Rockville, MD

Track Institutional and Insider Activities on SNSE

Follow Sensei Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNSE shares.

Notify only if

Insider Trading

Get notified when an Sensei Biotherapeutics, Inc. insider buys or sells SNSE shares.

Notify only if

News

Receive news related to Sensei Biotherapeutics, Inc.

Track Activities on SNSE